1. Home
  2. Analysis
  3. Hep-lock
  4. Swallowing-difficulty

Hep-lock and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Hep-lock (heparin sodium), especially for people who are female, 40-49 old, also take Xeloda, and have Metastases to bone.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Hep-lock. It is created by eHealthMe based on reports of 134 people who have side effects when taking Hep-lock from the FDA, and is updated regularly.

What is Hep-lock?

Hep-lock has active ingredients of heparin sodium. eHealthMe is studying from 135 Hep-lock users. Check the latest studies of Hep-lock.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 10, 2026

134 people reported to have side effects when taking Hep-lock.
Among them, 11 people (8.21%) have Swallowing difficulty.

Could Hep-lock cause Swallowing difficulty?

Among these 11 people:

What is the gender of people who have Swallowing difficulty when taking Hep-lock? *

  • female: 63.64 %
  • male: 36.36 %

What is the age of people who have Swallowing difficulty when taking Hep-lock? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 87.5 %
  • 50-59: 0.0 %
  • 60+: 12.5 %

What are other drugs people take besides Hep-lock? *

  1. Xeloda: 9 people, 81.82%
  2. Zometa: 8 people, 72.73%
  3. Decadron: 8 people, 72.73%
  4. Coumadin: 8 people, 72.73%
  5. Faslodex: 8 people, 72.73%
  6. Flagyl: 8 people, 72.73%
  7. Zofran: 8 people, 72.73%
  8. Aredia: 8 people, 72.73%
  9. Protonix: 8 people, 72.73%
  10. Prednisone: 8 people, 72.73%

What are other side effects people have besides Swallowing difficulty? *

  1. Weakness: 11 people, 100.00%
  2. Fatigue (feeling of tiredness): 11 people, 100.00%
  3. Abdominal Pain: 9 people, 81.82%
  4. Weight Decreased: 9 people, 81.82%
  5. Dyspnea (difficult or laboured breathing): 9 people, 81.82%
  6. Fever: 9 people, 81.82%
  7. Metastases To Spine (cancer spreads to spine): 8 people, 72.73%
  8. Wheezing (a high-pitched whistling sound made while you breath): 8 people, 72.73%
  9. Infection: 8 people, 72.73%
  10. Lymphocyte Percentage Decreased: 8 people, 72.73%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 8 people, 72.73%
  2. Prostate Cancer Metastatic: 2 people, 18.18%
  3. Renal Cell Carcinoma (a kidney cancer): 1 person, 9.09%
  4. Pancreatic Carcinoma (pancreatic cancer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hep-lock and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hep-lock:

Swallowing difficulty treatments and more:

How severe was Swallowing difficulty and when was it recovered:

Expand to all the drugs that have ingredients of heparin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hep-lock:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Browse all the conditions that are associated with Swallowing difficulty:

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Hep-lock) and Hep-lock (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.